A Rare Case of Paratesticular Rhabdomyosarcoma in an Infant: Surgical and Pathologic Perspectives

Authors

  • Madhuri Sethia Department of Pathology, Maulana Azad Medical College, New Delhi, India
  • Reena Tomar Department of Pathology, Maulana Azad Medical College, New Delhi, India
  • Sujoy Neogi Department of Paediatric Surgery, Maulana Azad Medical College, New Delhi, India
  • Lekshmi Satheesh Department of Paediatric Surgery, Maulana Azad Medical College, New Delhi, India

DOI:

https://doi.org/10.21276/apalm.3991

Keywords:

rhabdomyosarcoma, paratesticular, scrotal sac, immunohistochemistry

Abstract

Background: Paratesticular spindle cell rhabdomyosarcoma is an extremely rare soft tissue sarcoma, accounting for only about 5% of all paratesticular rhabdomyosarcomas. It primarily affects children and adolescents, with very few cases reported in infants.

Case Summary: A 5-month-old baby presented with a painless mass in left scrotal sac, detected incidentally during a routine vaccination visit. Clinical examination revealed a firm, non-tender mass inseparable from the left testis. High inguinal orchidectomy was performed and the specimen was sent for histopathological examination. Histopathology along with immunohistochemistry established the diagnosis of spindle cell rhabdomyosarcoma of the paratesticular region.

Conclusion: Paratesticular spindle cell rhabdomyosarcoma, though rare in infancy, should be considered in the differential diagnosis of painless scrotal masses. Early detection due to superficial location, complete surgical resection and adjuvant VAC chemotherapy offers a favourable prognosis. However, long-term follow-up is essential.

References

1. Kumar R, Kapoor R, Khosla D, Kumar N, Ghoshal S, Mandal AK, et al. Paratesticular rhabdomyosarcoma in young adults: A tertiary care institute experience. Indian J Urol. 2013 Apr;29(2):110-3. doi: 10.4103/0970-1591.114030. PMID: 23956511; PMCID: PMC3737665.

2. Kura MM, Umar AM, Arogundade AK, et al. Giant primary paratesticular rhabdomyosarcoma: a case report and review of surgical and oncologic management. Afr J Urol. 2025;31:24. https://doi.org/10.1186/s12301-025-00497-8

3. Ferrari A, Casanova M, Massimino M, Luksch R, Piva L, Fossati-Bellani F. The management of paratesticular rhabdomyosarcoma: a single institutional experience with 44 consecutive children. J Urol. 1998 Mar;159(3):1031-4. doi: 10.1016/s0022-5347(01)63830-8. PMID: 9474226.

4. Childhood Rhabdomyosarcoma Treatment (2024) https://www.cancer.gov/types/soft-tissue-sarcoma/hp/rhabdomyosarcoma-treatment-pdq. Accessed 10 Oct 2024.

5. WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours. WHO Classification of Tumors, 5th Edition, Volume 3. Lyon: IARC; 2020.

6. Dey B, Bharti JN, Dange P, Desai PA, Khurana N, Chander J. Paratesticular spindle cell rhabdomyosarcoma. Rare Tumors. 2015;7(3):64-65. doi: 10.4081/rt.2015.5823

7. Skapek SX, Ferrari A, Gupta AA, Lupo PJ, Butler E, Shipley J, et al. Rhabdomyosarcoma. Nature Reviews Disease Primers. 2019 Jan 7;5(1):1.

8. Gupta AA, Xue W, Harrison DJ, Hawkins DS, Dasgupta R, Wolden S, et al. Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group. The Lancet Oncology. 2024 Jul 1;25(7):912-21.

Downloads

Published

06-10-2026

Issue

Section

Case Report / Case Series

How to Cite

1.
A Rare Case of Paratesticular Rhabdomyosarcoma in an Infant: Surgical and Pathologic Perspectives. Ann of Pathol and Lab Med [Internet]. 2026 Oct. 6 [cited 2026 Nov. 10];13(11):C290-C293. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/3991